FDA.reportPublic FDA data

GABAPENTIN

Product NDC
53002-1472
11-digit product format
530021472
Labeler code
53002
Product ID
53002-1472_8695619f-99fd-4255-9a1f-a722284b334c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
GABAPENTIN
Dosage form
CAPSULE
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA090705
Marketing category
ANDA
Marketing start
2016-06-29
Marketing end
0000-00-00
Substance
GABAPENTIN
Active strength
100 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53002-1472-02025-01-30C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-32025-01-30C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-62025-01-30C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-02023-06-07C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-32023-06-07C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-62023-06-07C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-02023-01-30C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-32023-01-30C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-62023-01-30C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-02020-12-15C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-32020-12-15C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-62020-12-15C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-02020-01-31C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-32020-01-31C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993
53002-1472-62020-01-31C16284748780-19d75b9d0-f3d9-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53002-1472-0GABAPENTIN100 in 1 BOTTLECAPSULE1009
53002-1472-3GABAPENTIN30 in 1 BOTTLECAPSULE309
53002-1472-6GABAPENTIN60 in 1 BOTTLECAPSULE609

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53002-1472GABAPENTIN CAPSULE [RPK PHARMACEUTICALS, INC.]9Legacy NDC, 3 package rows20230609_783af1df-dbcc-41c9-bbd6-fcb3d2838153.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310430gabapentin 100 MG Oral CapsulePSN783af1df-dbcc-41c9-bbd6-fcb3d28381539
310431gabapentin 300 MG Oral CapsulePSN783af1df-dbcc-41c9-bbd6-fcb3d28381539
310430gabapentin 100 MG Oral CapsuleSCD783af1df-dbcc-41c9-bbd6-fcb3d28381539
310431gabapentin 300 MG Oral CapsuleSCD783af1df-dbcc-41c9-bbd6-fcb3d28381539

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
53002-1472-053002147200100 CAPSULE in 1 BOTTLE (53002-1472-0) 100 capsule2017-09-010000-00-00NoNoCurrent
53002-1472-35300214720330 CAPSULE in 1 BOTTLE (53002-1472-3) 30 capsule2017-09-010000-00-00NoNoCurrent
53002-1472-65300214720660 CAPSULE in 1 BOTTLE (53002-1472-6) 60 capsule2017-09-010000-00-00NoNoCurrent